Why Abercrombie & Fitch Won Big Despite a Q2 Loss
Abercrombie & Fitch reported better than expected fiscal second-quarter financial results before the markets opened on Thursday.
All Work
Chris Lange
HP Earnings Beat Not Enough for Investors
HP Inc. (NYSE: HPQ) reported its fiscal third-quarter financial results after the markets closed on Wednesday. The firm said that it had $0.43 in earnings per share (EPS) on $13.1 billion in revenue, compared…
Wednesday’s Biggest Winners and Losers in the S&P 500
The U.S. broad markets backed off Wednesday after having one of the best trading days of the year on Tuesday. Crude oil was positive on the day and Oil & Gas stocks responded in…
Why Jefferies Sees Huge Upside in Fiat Chrysler
Shares of Fiat Chrysler saw a handy gain on Wednesday after the auto manufacturer received the nod from a key analyst. This comes after the company has reportedly been in talks with a Chinese…
What to Expect When HP Reports After the Close
Since the company split in late 2015, HP has made solid gains, although it did take a dip first. The upcoming earnings report could set the stage for the company to continue pushing its…
What Analysts Are Saying About Salesforce After Earnings
Salesforce.com released its most recent earnings report late Tuesday, and analysts overall responded positively.
Why American Eagle Outfitters Is Bucking the Retail Trend
It seems that this retailer was able to buck the trend with these most recent results, and on the back of solid comparable sales.
Ultragenyx Stumbles Over Late-Stage Trial
Ultragenyx Pharmaceutical shares took a turn for the worse on Wednesday after a report that results from its late-stage trial did not live up to expectations.
Intra-Cellular Soars on Critical FDA Update
Intra-Cellular Therapies saw its shares make an incredible gain early on Wednesday after the FDA gave a positive regulatory update on the firm’s schizophrenia program.
Salesforce Sinks Despite Beating Earnings
Salesforce.com, Inc. (NYSE: CRM) reported its fiscal second-quarter financial results after the markets closed on Tuesday. The company said that it had $0.33 in earnings per share (EPS) and $2.56 billion in revenue, compared…
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a very strong day for the U.S. broad markets with all major indices posting a gain on the day. Crude oil was positive as well after having fallen over the course of…
What to Expect From Lowe’s Earnings
Lowe’s is scheduled to release most recent quarterly earnings report before the markets open on Wednesday, after rival Home Depot beat expectations when it reported last week.
Why Momo Is Tanking Despite Explosive Growth
Chinese social network Momo reported better-than-expected fiscal second-quarter financial results before the markets opened on Tuesday, but shares tanked.
What to Expect When Salesforce Reports After the Close
Salesforce.com is set to release its fiscal second-quarter financial earnings report after the markets close on Tuesday. What can investors expect?
How Kohl’s Is Revamping Its Format
Management believes that the company is continuing to make progress on its initiatives to optimize and rightsize select Kohl’s stores across the country.
DSW Wins Big in Q2
Retailer DSW reported better-than-expected fiscal second-quarter financial results before the markets opened on Tuesday.
Krystal Biotech Files for IPO
Gene therapy company Krystal Biotech has filed with the SEC regarding its initial public offering.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a relatively flat day for the broad markets on very low volume, as the result of a once-in-a-lifetime solar eclipse that took place across the U.S. The eclipse lasted about 2 hours…
Coherus Bio Jumps on Private Placement
Coherus Biosciences, Inc. (NASDAQ: CHRS) watched its shares jump on Monday after the company announced that it plans to raise up to $150 million in a two tranche private placement. A Singapore investment firm,…
Ironwood Pharma Muted Despite FDA Approval
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares remained relatively muted on Monday after the firm announced a key U.S. Food and Drug Administration (FDA) approval for its gout treatment duzallo. The firm expects duzallo to…